January 20, 2022 — Leading health tech firm Qure.ai has gained 510(k) clearance from the Food and Drug Administration (FDA) for an artificial intelligence (AI) algorithm called qXR-BT, that will help doctors in assessing Breathing Tube (BT) placements.

The Great Resignation has impacted every industry, including ours.

The Great Resignation has impacted every industry, including ours. While this movement will be studied for years to come, it’s tough to argue that the pandemic has not accelerated the shift in the workforce.
Vendor neutral archives (VNAs) have become a staple within the healthcare IT system.

Vendor neutral archives (VNAs) have become a staple within the healthcare IT system.
The Viz.AI pulmonary embolism response team (PERT) app that uses AI to detect PE on images before they go into PACS, alerts the PERT team members and provides a mobile platform to message, review images and other patient data. Photo by Dave Fornell

Artificial intelligence (AI) has found a unique niche to help automate the activation of acute care teams for pulmonary embolism (PE), aortic dissections and abdominal aortic aneurysms (AAA) and allow them access to imaging and immediate communications.
In February 2021, Guerbet announced the launch of OptiProtect 3S (Smart Service Solutions), a range of technical services for its injection solutions. OptiProtect 3S is designed to support imaging centers in the daily use and protection of their injection solutions.

Contrast media injectors are used to inject contrast agents to enhance the blood and perfusion in tissues. There have been several recent advances with contrast media injector technology, including cutting costs by reducing contrast waste and automated data collection for the dose a patient receives.
A 26-year-old man with history of diabetes and hypertension presented with 7 days of fever, chills, nausea, intractable vomiting, diarrhea and generalized weakness, but no specific upper or lower respiratory symptoms aside from mild shortness of breath.

A 26-year-old man with history of diabetes and hypertension presented with 7 days of fever, chills, nausea, intractable vomiting, diarrhea and generalized weakness, but no specific upper or lower respiratory symptoms aside from mild shortness of breath. The patient was diaphoretic and retching on arrival. Physical examination showed diffuse abdominal tenderness, mild tachypnea and tachycardia.

The most common cause of chronic liver disease? Nonalcoholic fatty liver disease (NAFLD).

The New Year always brings change, which opens many doors to new possibilities. In 2022, Imaging Technology News will be working hard to bring its audience exclusive, informative coverage, including the new Clinical Case of the Month section. On many of our pages you also will find QR codes that you can snap a picture of to view extended information on certain topics, including videos, related content and podcasts.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now